APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 188 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $259,623 | -58.8% | 6,825 | -1.4% | 0.01% | -57.1% |
| Q2 2023 | $630,321 | +30.2% | 6,919 | -5.7% | 0.02% | +5.0% |
| Q1 2023 | $484,212 | +28.9% | 7,341 | +1.1% | 0.02% | +11.1% |
| Q4 2022 | $375,518 | -99.9% | 7,262 | -0.5% | 0.02% | -28.0% |
| Q3 2022 | $498,385,000 | +150925.8% | 7,297 | 0.0% | 0.02% | +66.7% |
| Q2 2022 | $330,000 | -28.4% | 7,297 | -19.5% | 0.02% | -16.7% |
| Q1 2022 | $461,000 | +53.7% | 9,069 | +43.2% | 0.02% | +80.0% |
| Q4 2021 | $300,000 | -47.5% | 6,335 | -29.9% | 0.01% | -50.0% |
| Q2 2021 | $571,000 | +68.9% | 9,041 | +14.7% | 0.02% | +42.9% |
| Q1 2021 | $338,000 | – | 7,881 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |